ARKG
- ARK Genomic Revolution ETFInformations clés
| Date la plus ancienne | 2014-10-31 |
Informations sur l'ETF
| Émetteur du fonds | ARK Invest |
| Indice | Active (No Index) |
| Frais de gestion | 0.75% |
| Nombre de positions | 42 |
| Date de création | 2014-10-31 |
| Classe d'actifs | Equity |
| Cotation | US-listed |
| Secteur | Healthcare |
| Style d'investissement | Growth |
| Sans effet de levier | Non-leveraged |
À propos de ARKG
The ARK Genomic Revolution ETF is an actively managed fund that invests in companies driving advancements in genomics, gene editing, genetic therapy, molecular diagnostics, and stem cell advances. The fund's portfolio is tilted towards smaller firms and is designed to capture long-term growth potential in the healthcare and biotechnology sectors.